UMU logo

BBVA Foundation Frontiers of Knowledge Award in Biomedicine 2017

BBVA Foundation
[207-06-15] The Banco Bilbao Vizcaya Argentaria (BBVA) presented the recipients of the 9th BBVA Foundation Frontiers of Knowledge Awards during the ceremony on June 15, 2017 in Bilbao, Spain. The BBVA Group Executive Chairman Francisco González handed out the Foundations Award in Biomedicine 2017 to Emmanuelle Charpentier, Jennifer Doudna, and Francisco Martínez Mojica for "developing CRISPR, the most efficient and precise gene-editing technique.

The BBVA Foundation Frontiers of Knowledge Awards were established in 2008. They "recognize contributions with the power to enlarge and transform our understanding of the world, and to train a spotlight on their creators". The awards are endowed with a total €3,2 million which are distributed among the categories and awardees.

Read more about:
the BBVA Foundation Frontiers of Knowledge Award Ceremony
the BBVA presentation of the three Awardees(picture: BBVA Foundation Frontiers of Knowledge Awards)

The 33rd Japan Prize awarded to Emmanuelle Charpentier

[2017-02-03] The Japan Prize Foundation announced at its press conference on 1st of February 2017 that the 33rd Japan Prize is awarded to Emmanuelle Charpentier and Jennifer Doudna. The Japan Prize honors annually scientists and engineers from around the world who have made significant contributions to the advancement of science and tehnology, thereby furthering the cause of peace and prosperity of mankind.

Emmanuelle Charpentier and Jennifer Doudna are awarded as Trailblazers in Life Science for there work which "deciphered CRISPR-Cas9, creating a revolutionary tool for editing DNA".

At the prize ceremony, on 3rd February 2017 also Adi Shamir, Weizmann Institute of Science, Israel, was honored in the field of "Electronics, Information and communication" for his "contribution to information security through pioneering research on cryptography".

More information:

Website of The Japan Prize Foundation


Watch the 2017 Japan Prize Press Conference:

The Japan Prize press conference 3rd February 2017

“Limited only by the Imagination” - Emmanuelle Charpentier awarded the Tang Prize 2016

Tang Prize Logo[2016-06-20] The 2016’s Tang Prize in Biopharmaceutical Science recognizes Emmanuelle Charpentier together with Jennifer Doudna and Feng Zhang “for the development of CRISPR/Cas9 as a breakthrough genome editing platform that promises to revolutionize biomedical research and disease treatment”.

Dr. Charpentier’s research focuses on mechanisms of regulation in infection and immunity. Her laboratory strives to understand how RNA and protein molecules work together to control gene expression and biological processes in bacterial pathogens. To identify new molecules and decipher their origins, functions and modes of action at the molecular and cellular level, Dr. Charpentier applies a combination of a wide range of methods, including -omics, genetics, molecular biology, biochemistry, physiology as well as cell infection approaches.

Read more: “Limited only by the Imagination” - Emmanuelle Charpentier awarded the Tang Prize 2016

Cpf1: CRISPR-enzyme scissors cutting both RNA and DNA

[2016-04-20] Scientists delineate molecular details of a new bacterial CRISPR-Cpf1 system and open possible avenue for alternative gene editing uses like targeting several genes in parallel. (Nature 20 April 2016)

Only a few years after its discovery, it is difficult to conceive of genetics without the CRISPR-Cas9 enzyme scissors, which allow for a very simple, versatile and reliable modification of DNA of various organisms. Since its discovery, scientists throughout the world have been working on ways of further improving or adjusting the CRISPR-Cas9 system to their specific needs. Researchers from the Max Planck Institute for Infection Biology in Berlin, the Umeå University in Sweden and the Helmholtz Centre for Infection Research in Braunschweig have now discovered a feature of the CRISPR-associated protein Cpf1 that has previously not been observed in this family of enzymes: Cpf1 exhibits dual, RNA and DNA, cleavage activity. In contrast to CRISPR-Cas9, Cpf1 is able to process the pre-crRNA on its own, and then using the processed RNA to specifically target and cut DNA. Not requiring a host derived RNase and the tracrRNA makes this the most minimalistic CRISPR immune system known to date. The mechanism of combining two separate catalytic moieties in one allows for possible new avenues for sequence specific genome engineering, most importantly facilitation of targeting multiple sites at once, the so-called multiplexing.

Read more: Cpf1: CRISPR-enzyme scissors cutting both RNA and DNA

Canadian Gairdner Award to Emmanuelle Charpentier

[2016-03-23] The Gairdner Foundation is awarding Emmanuelle Charpentier and four other scientists with the Gairdner International Award 2016, Canada's most prestigious medical award.

The laureates will be awarded in October during a visit in Canada to speak with faculty and students at 20 universities in the country. The Canada Gairdner International Award is given to "biomedical scientists who have made original contributions to medicine resulting in increased understanding of human biology and disease". Each award is valued $ 100,000 CDN, supported by the Canadian government. Emmanuelle Charpentier is honored "for development of CRISPR-CAS as a genome editing tool for eukaryotic cells".

Read more on the webpage of  the Gairdner Foundation

Doctor of Science degree honoris causa from New York University

[16-03-10] Emmanuelle Charpentier is one of the recipients of a honoris causa doctorate degree from New York University. The university will honor Emmanuelle Charpentier as "a scientist whose research led to some of the most important tools for genome editing" together with the other recipients of honorary doctorates at the 184th Commencement Exercises on May 18, 2016 in the Yankee Stadium, New York.

Read the press release of New York University

Warren Alpert Foundation Prize 2016

WAFoundation Prize Logo[16-03-09] The Warren Alpert Foundation announces Emmanuelle Charpentier to be one of the five recipients of the Warren Alpert Foundation Prize 2016.

The awardess will receive their prize on 6 October at Harvard Medical School.

The five receipients are recognised for their "for their remarkable contributions to the understanding of the CRISPR bacterial defense system and the revolutionary discovery that it can be adapted for genome editing.
Emmanuelle will receive the prize together with Rudolphe Barrangou, Phillippe Horvath, Virgnijus Siksnys and Jennifer Doudna.

Read the press release from the Warren Alpert Foundation and Harvard Medical School

Paul Ehrlich- und Ludwig Darmstaedter Preis 2016 for Emmanuelle Charpentier

[2016-01-25] The Paul Ehrlich Foundation at the Goethe University in Frankfurt am Main, Germany, announced that Emmanuelle Charpentier will receive the Paul Ehrlich- und Ludwig Darmstaedter-Preis 2016 on Paul Ehrlich's birthday, March 14th, at the St. Paul Church in Frankfurt. The Ehrlich Prize is among the most prestigious awards, which are presented to international scientists in Germany in the field of medicine.

The prize honors scientists who have acquired merits in one of the research fields of Paul Ehrlich especially immunology, cancer research, hematology, microbiology and chemotherapy.

play Press release of the Paul Ehrlich Foundation (in German)

footer all slides 2014-02-06

Copyright © 2017 by The Laboratory for Molecular Infection Medicine Sweden (MIMS). All rights reserved.